(Total Views: 62)
Posted On: 10/21/2019 4:05:41 PM
Post# of 27277
$VRTX News Article - FDA Approves TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older Who Have at Least One F508del Mutation https://marketwirenews.com/news-releases/fda-...15684.html
(0)
(0)
My Twitter: WhyteStocks
